STTR Phase II: Compact Aberration Compensated Focus and Scan Control for Biomedical Sensors

这个小型企业技术转让（STTR）第二阶段项目将开发一种像差补偿聚焦控制装置的商业原型。该装置基于MEMS技术，将允许用户以可控的方式偏转可变形的膜镜，以选择所需的焦距。该装置还具有对低阶像差的主动控制。这项技术将使下一代生物医学成像设备用于显微镜应用，使焦点控制和像差校正在一个简单，紧凑和低成本的传感器。这项研究的更广泛的影响主要是在生物医学成像。一个行业合作伙伴有兴趣使用该技术的像差校正能力，以提高皮肤癌检测与他们的共聚焦显微镜产品线。亚利桑那大学的显微镜和内窥镜研究人员表示，这项技术将是他们对抗癌症研究的宝贵资产。该公司还将与MEMS技术的公认领导者合作，以增强成像能力，主要用于眼科领域的成像。

This Small Business Technology Transfer (STTR) Phase II project will develop a commercial prototype of an aberration compensated focus control device. This device, based on a MEMS technology, will allow the user to deflect a deformable membrane mirror in a controlled manner in order to select a desired focal length. The device also features active control of low-order aberrations. This technology will enable the next generation of biomedical imaging devices for microscopy applications by enabling focus control and aberration correction in a simple, compact and low-cost sensor.The broader impacts of this research are primarily in biomedical imaging. An industry partner is interested in using the technologys aberration correction capabilities to improve skin cancer detection with their confocal microscopy product line. Microscopy and endomicroscopy researchers at the University of Arizona have stated that this technology will be a valuable asset in their research in the fight against cancer. The company will also team with a recognized leader in MEMS technology to enable enhanced imaging capabilities, primarily for imaging in the field of ophthalmology.